Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

agilon health Inc (AGL)

  • Business News
  • Jan. 15, 2026, 14:00 UTC
  • 4
  • 1 comments

The Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AGL

Market reaction Comment Full text

Phio Pharmaceuticals Corp. (PHIO)

  • Business News
  • Jan. 15, 2026, 13:46 UTC
  • 5
  • 1 comments

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026

Market reaction Comment Full text

Propanc Biopharma, Inc. (PPCB)

  • Business News
  • Jan. 15, 2026, 13:45 UTC
  • 5
  • 1 comments

Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer

Market reaction Comment Full text

HCA Holdings Inc (HCA)

  • Business News
  • Jan. 15, 2026, 13:30 UTC
  • 7
  • 1 comments

HCA Healthcare - HCA Healthcare Names Erica Rossitto as Chief Nurse Executive

Market reaction Comment Full text

GT Biopharma Inc. (GTBP)

  • Business News
  • Jan. 15, 2026, 13:30 UTC
  • 8
  • 1 comments

GT Biopharma Announces IND Submission for GTB-5550TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers

Market reaction Comment Full text

Agenus Inc. (AGEN)

  • Business News
  • Jan. 15, 2026, 13:30 UTC
  • 6
  • 1 comments

Zydus Lifesciences Limited completes the acquisition of Agenus Inc.s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.

Market reaction Comment Full text

Neurocrine Biosciences Inc (NBIX)

  • Business News
  • Jan. 15, 2026, 13:30 UTC
  • 8
  • 1 comments

Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR

Market reaction Comment Full text

Hoth Therapeutics Inc (HOTH)

  • Business News
  • Jan. 15, 2026, 13:17 UTC
  • 6
  • 1 comments

Hoth Therapeutics Notification (HOTH)

Market reaction Comment Full text

Hyperfine Inc (HYPR)

  • Business News
  • Jan. 15, 2026, 13:15 UTC
  • 8
  • 1 comments

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Market reaction Comment Full text

Cognex Corporation (CGNX)

  • Business News
  • Jan. 15, 2026, 13:03 UTC
  • 7
  • 1 comments

Cognex Corporation - Cognex Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates

Market reaction Comment Full text
  • Previous
  • 52
  • 53
  • 54
  • 55
  • 56
  • Next

Search

News categories

  • Technical Exchange News(10847)
  • Event(2223)
  • SEC News(187893)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124366)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin